Valuation and Modeling of EQ-5D-5L Health States Using a Hybrid Approach
暂无分享,去创建一个
Mark Oppe | Juan M Ramos-Goñi | Jose L Pinto-Prades | Juan M Cabasés | Pedro Serrano-Aguilar | Oliver Rivero-Arias | O. Rivero-Arias | J. Cabasés | P. Serrano-Aguilar | J. Pinto-Prades | M. Oppe | J. Ramos-Goñi
[1] Mark Oppe,et al. Discrete choice modeling for the quantification of health states: the case of the EQ-5D. , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[2] S. Hawkins,et al. Information Processing Strategies in Riskless Preference Reversals: The Prominence Effect , 1994 .
[3] Stephen Joel Coons,et al. US Valuation of the EQ-5D Health States: Development and Testing of the D1 Valuation Model , 2005, Medical care.
[4] G. W. Fischer,et al. Strategy compatibility, scale compatibility, and the prominence effect. , 1993 .
[5] Mark Oppe,et al. From a different angle: a novel approach to health valuation. , 2010, Social science & medicine.
[6] John M. Rose,et al. Applied Choice Analysis: A Primer , 2005 .
[7] J. L. Pinto,et al. Loss aversion and scale compatibility in two-attribute trade-offs , 2002 .
[8] Mark Oppe,et al. A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[9] M. Cowie. National Institute for Health and Care Excellence. , 2015, European heart journal.
[10] R F Nease,et al. Choice-Matching Preference Reversals in Health Outcome Assessments , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.
[11] Anthony O'Hagan,et al. Using rank data to estimate health state utility models. , 2006, Journal of health economics.
[12] Florian Nadel,et al. Eq 5d Value Sets Inventory Comparative Review And User Guide , 2016 .
[13] I. Simonson,et al. Price–Quality Trade-Offs in Choice Versus Matching: New Insights Into the Prominence Effect , 1998 .
[14] Mark Oppe,et al. EQ-5D value sets : inventory, comparative review, and user guide , 2007 .
[15] Joshua A Salomon,et al. Reconsidering the use of rankings in the valuation of health states: a model for estimating cardinal values from ordinal data , 2003, Population health metrics.
[16] Angela Robinson,et al. Exploring challenges to TTO utilities: valuing states worse than dead. , 2006, Health economics.
[17] A. Williams. EuroQol : a new facility for the measurement of health-related quality of life , 1990 .
[18] P. Dolan,et al. Modeling valuations for EuroQol health states. , 1997, Medical care.
[19] Paul F. M. Krabbe,et al. The development of new research methods for the valuation of EQ-5D-5L , 2013, The European Journal of Health Economics.
[20] M. Bliemer,et al. Approximation of bayesian efficiency in experimental choice designs , 2008 .
[21] Michael Herdman,et al. Dealing with the health state ‘dead’ when using discrete choice experiments to obtain values for EQ-5D-5L heath states , 2013, The European Journal of Health Economics.
[22] Yan Zhang,et al. The Prominence Effect in Shanghai Apartment Prices , 2008 .
[23] G. Bonsel,et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) , 2011, Quality of Life Research.
[24] Murtuza Bharmal,et al. Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population. , 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[25] Christopher K. Hsee,et al. Preference Reversals between Joint and Separate Evaluations of Options: A Review and Theoretical Analysis , 1999 .
[26] Mark Oppe,et al. Introducing the composite time trade-off: a test of feasibility and face validity , 2013, The European Journal of Health Economics.
[27] A. Tversky,et al. Contingent weighting in judgment and choice , 1988 .
[28] A. Kasuya. EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.
[29] T. Kohlmann,et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[30] Mark Oppe,et al. Lead versus lag-time trade-off variants: does it make any difference? , 2013, The European Journal of Health Economics.
[31] P. Kind,et al. A Comparison of United Kingdom and Spanish General Population Time Trade-off Values for EQ-5D Health States , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.
[32] Adam Oliver,et al. Further evidence of preference reversals: choice, valuation and ranking over distributions of life expectancy. , 2006, Journal of health economics.